IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Andrus Anderson
- Dechert LLP
- Edelson Lechtzin
- Shipman & Goodwin
- Krantz & Berman
- McCune Law
- Fiddler Gonzalez
- Berman Tabacco
- Lieff Cabraser
- Barnes & Thornburg
- Ahern & Associates
- Anselmi & Carvelli
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- Armstrong Teasdale
- Levin Sedran
- Kohn Swift
- Steptoe LLP
- Motley Rice
- Tostrud Law Group
- Gross & Belsky
- Dilworth Paxson
- Freedman Boyd
- Obermayer Rebmann
- Girard Sharp
- Steyer Lowenthal
- Foley & Lardner
- Cera LLP
- Saiber LLC
- Crowell & Moring
- Stradley Ronon
- Faegre Drinker
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Schneider Wallace
- Hach Rose Schirripa
- Cuneo Gilbert
- Kirkland & Ellis
- Welsh & Recker
- DeCotiis FitzPatrick
- Pendley Baudin
- Shapiro Arato
- Lite DePalma
- Hogan Lovells
- Bailey & Glasser
- Joseph Saveri Law Firm
- Competition Law Partners
- Zwerling Schachter
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Dugan Law Firm
- Neufeld Scheck
- Spector Roseman
- Wexler Boley
- Goldman Scarlato
- Heins Mills
- Berry Law LLC
- Seeger Weiss
- Zelle LLP
- Hunt Ortmann
- King & Spalding
- Hughes Hubbard
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Reed Smith
- Debevoise & Plimpton
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Lyden Chappell
- Simpson Thacher & Bartlett LLP
- Segal McCambridge
- Calcaterra Pollack
- Patterson Belknap
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Napoli Shkolnik
- Carella Byrne
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Bailey Duquette
- Winston & Strawn
- Francis Mailman
- Boies Schiller
- O'Melveny & Myers
- Baker & Hostetler
- Neal & Harwell
- Nussbaum Law Group
- White and Williams
- Kaplan Fox
- Cleary Gottlieb
- Marks O'Neill
- Tycko & Zavareei
- Zuckerman Spaeder
- Barrett Law Group
- Troutman
- Duane Morris
- Williams & Connolly
- Cozen O'Connor
- Scott&Scott
- Miller & Chevalier
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Larson King
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Haynes Boone
- Langer Grogan
- Lewis Brisbois
- Weil Gotshal
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Grabar Law
- Stevens & Lee
- Sills Cummis
- NastLaw
- Berger Montague
- Skadden Arps
- Rule Garza
- Garwin Gerstein
- DiCello Levitt
- Radice Law Firm
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- Proskauer Rose
- Morgan Lewis
- Wolf Haldenstein
- Arnold & Porter
- Tarter Krinsky
- Cotchett Pitre
- Taus Cebulash
- Spiro Harrison
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- DLA Piper
- Freshfields
- Norton Rose
- Bingham McCutchen
- Lowenstein Sandler
- Ballard Spahr
- Cole Schotz
- Gustafson Gluek
- Baker Botts
- Goodwin Procter
- Clark Hill
- Wilson Sonsini
- Seward & Kissel
- Whatley Kallas
- Miller Shah
- Cohen Milstein
- Morrison Foerster
- Robbins Geller
- O’Neill & Borges
- Sperling Kenny
- Earp Cohn
- McDermott Will & Emery
- Zimmerman Reed
- Glancy Prongay
- Harris St. Laurent
- Constantine Cannon
- K&L Gates
- Fox Rothschild
- Polsinelli PC
- Venable LLP
- Blank Rome
- WilmerHale
- Linklaters LLP
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Sandoz International GmbH
- Impax Laboratories, Inc.
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Novartis AG
- Endo International PLC
- Aurobindo Pharma Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Viatris Inc.
- Humana Inc.
- Hi-Tech Pharmacal Co., Inc.
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Dr. Reddy's Laboratories Ltd.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Red Oak Sourcing LLC
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Cencora Inc.
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
April 02, 2024
Healthcare In Court: Idaho AG Not 'Cute' On Abortion Ban
Idaho's solicitor general had a hard day at the Ninth Circuit, where a panel tried and failed to get a lock on the state attorney general's stance on Idaho's abortion ban. Home Depot pressed the U.S. Supreme Court to review a $2.67 billion settlement in antitrust litigation against the Blue Cross Blue Shield Association. And in Texas, a woman charged with murder for inducing her own abortion sued the prosecutors behind the case.
-
March 27, 2024
NY AG, Others Blast Sandoz Deal 'Tax' On Future Settlements
New York's attorney general was one of three objectors Tuesday to a provision in Sandoz's proposed $265 million settlement with a class of drug wholesalers in Pennsylvania federal court that they say will delay any future generic-drug price-fixing litigation deals by taxing agreements over $119.25 million.
-
March 14, 2024
Drug Wholesalers Want Preliminary OK On $265M Sandoz Deal
A group of direct purchasers of generic drugs has asked a Pennsylvania federal court for approval of a $265 million settlement with Swiss drugmaker Sandoz over allegations of federal antitrust violations.
-
February 29, 2024
Sandoz To Pay $265M To Resolve Claims In Price-Fixing MDL
Swiss generic drug and biosimilar manufacturer Sandoz announced Thursday that two of its subsidiaries have reached a $265 million settlement with the direct purchasers of generic medications to resolve allegations of federal antitrust violations.
-
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
A Pennsylvania federal judge granted preliminary approval Wednesday to settlements in which two makers and one distributor of generic drugs agreed to pay a combined $45 million to resolve allegations they colluded to fix the prices of medications, including those used to treat glaucoma, high blood pressure and high cholesterol.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
January 23, 2024
3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
Generic-drug makers Apotex Corp., Heritage Pharmaceuticals Ltd. and Breckenridge Pharmaceutical Inc. have each agreed to shell out a combined $45 million to settle allegations they colluded to fix the prices of many medications, according to a trio of motions filed Tuesday in multidistrict litigation in Pennsylvania federal court.
-
January 17, 2024
Generic-Drug Cos. Say States Are Mum In MDL Discovery
Generic-drug makers steeped in antitrust multidistrict litigation are asking for an order enforcing a months-old deadline for documents that most states have ignored, according to a memorandum filed in Pennsylvania federal court.
-
December 07, 2023
Generics Price-Fixing Cases Should Stay In MDL, Judge Says
The Pennsylvania federal judge overseeing sprawling multidistrict litigation against generic-drug makers on Thursday told the U.S. Judicial Panel on Multidistrict Litigation that she does not recommend transferring state enforcer actions out of the MDL yet, saying there's more the court can do to get the cases ready for trial or to tee up settlement talks.
-
November 02, 2023
States Want Generic Drug Price-Fixing Claims Back In Conn.
State enforcers accusing several generic drugmakers of price-fixing asked the Judicial Panel on Multidistrict Litigation to move their case back to Connecticut federal court, saying legislation signed by President Joe Biden last year spares state enforcers from the MDL process.